http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101640161-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2008-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101640161-B1
titleOfInvention 6,7-dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
abstract In view of the infinite possibilities provided by quinazoline compounds, the present inventors have undertaken the synthesis and screening of a number of novel compounds with novel structural features. As a result, it has been surprisingly found that the quinazoline having a 3-ethynyl anilino group at position 4 and specifically having an alkoxy group substituted at positions 6 and 7 is more potent than the other known quinazoline drugs And have specific antiproliferative properties. Furthermore, surprisingly, the compounds according to the invention are significantly less toxic, and this safety profile is very advantageous in the therapeutic field. The novel compounds described in the present invention can be represented by the general structural formula (I) and have not been synthesized so far, and the usefulness and safety profile in the therapeutic field have not been disclosed. (A) structure, compound I is NRC-2694.
priorityDate 2008-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413029054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424508356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24990553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411682427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449192583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 39.